Globicatella bacteraemia identified by 16S ribosomal RNA gene sequencing

Journal of Clinical Pathology
Susanna K P LauK-Y Yuen

Abstract

Globicatella are streptococcus-like organisms that have been rarely isolated from clinical specimens. Their epidemiology and clinical significance remain largely unknown. To describe two cases of Globicatella bacteraemia identified by 16S ribosomal RNA (rRNA) gene sequencing. Two unidentified streptococcus-like bacteria isolated from blood cultures of patients were subject to 16S rRNA gene sequencing. Two cases of Globicatella bacteraemia were identified by 16S rRNA gene sequencing. In the first case, a gram positive coccus was isolated from the blood culture of an 80 year old woman with diabetes mellitus and nosocomial sepsis, who died the day after developing the bacteraemia. The bacterium was unidentified by conventional phenotypic tests, the Vitek (gram positive identification) and the ATB expression (ID32 Strep) systems. In the second case, a similar bacterium was isolated from the blood culture of a 92 year old woman with polymicrobial acute pyelonephritis complicated by septic shock, who subsequently recovered after antibiotic treatment. 16S rRNA gene sequencing of the two isolates showed 0.5% nucleotide difference from that of G. sulfidifaciens and 0.7% nucleotide difference from that of G. sanguinis, indicating that th...Continue Reading

References

Nov 1, 1992·The Journal of Applied Bacteriology·M D CollinsA M Williams
Jul 30, 1992·The New England Journal of Medicine·D A RelmanS Falkow
Oct 1, 1991·International Journal of Systematic Bacteriology·R W BentleyM D Collins
Dec 6, 1990·The New England Journal of Medicine·D A RelmanL S Tompkins
Jun 1, 1989·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·J J ChristensenH Kjaergaard
Nov 12, 1998·Trends in Biochemical Sciences·F JeanmouginT J Gibson
Oct 12, 2001·International Journal of Systematic and Evolutionary Microbiology·P VandammeF Haesebrouck
Mar 7, 2002·Journal of Clinical Microbiology·Patrick C Y WooKwok-Yung Yuen
Jan 25, 2003·Journal of Medical Microbiology·Patrick Chiu-Yat WooKwok-Yung Yuen
Mar 8, 2003·Journal of Clinical Microbiology·Susanna K P LauKwok-Yung Yuen
Aug 29, 2003·Journal of Clinical Pathology·P C Y WooK Y Yuen
Sep 16, 2003·Journal of Medical Microbiology·Rodney A LeeKwok-Yung Yuen
Oct 9, 2003·Journal of Clinical Microbiology·Susanna K P LauKwok-yung Yuen
Feb 10, 2004·Journal of Clinical Microbiology·Patrick C Y WooKwok-Yung Yuen
Feb 20, 2004·Diagnostic Microbiology and Infectious Disease·Patrick C Y WooKwok-yung Yuen
Oct 22, 2004·Journal of Medical Microbiology·Patrick Cy WooKwok-Yung Yuen

❮ Previous
Next ❯

Citations

Feb 12, 2010·Journal of Clinical Microbiology·Geneviève Héry-ArnaudAnne Bouvet
Nov 24, 2006·Journal of Clinical Microbiology·I SeegmüllerR R Reinert
Nov 15, 2011·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masatoshi MatsunamiNaoto Hosokawa
Oct 3, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·P C Y WooK-Y Yuen
Mar 1, 2012·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·Alfredo GarcíaSergio Sánchez
Jul 27, 2007·Scandinavian Journal of Infectious Diseases·Rawaa Jalil Abdul-RedhaMichael Kemp
Mar 6, 2021·Frontiers in Cellular and Infection Microbiology·Hailong DongQingxia Wu
Apr 12, 2021·Journal of Dairy Science·Conrado CarrascosaJosé R Jaber

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.